Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including early variants of concern: a test-negative design, British Columbia, Canada

Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson, Hind Sbihi, Chris D Fjell, Eleni Galanis, Monika Naus, David M Patrick, Shiraz El Adam, May Ahmed, Shinhye Kim, Bonnie Henry, Linda M N Hoang, Manish Sadarangani, Agatha N Jassem, Mel Krajden
doi: https://doi.org/10.1101/2021.09.20.21263875

Data Availability

Data sharing that complies with relevant legislation to protect privacy and confidentiality will be considered upon request.

Back to top
Posted September 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including early variants of concern: a test-negative design, British Columbia, Canada
Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson, Hind Sbihi, Chris D Fjell, Eleni Galanis, Monika Naus, David M Patrick, Shiraz El Adam, May Ahmed, Shinhye Kim, Bonnie Henry, Linda M N Hoang, Manish Sadarangani, Agatha N Jassem, Mel Krajden
medRxiv 2021.09.20.21263875; doi: https://doi.org/10.1101/2021.09.20.21263875
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area